This study found an association between use of probiotics among patients with CKD onhemodialysis, decreased levels of endothelial lesion markers (syndecan-1), andimproved lab parameters for blood glucose, hematocrit, and hemoglobin. This evidence concerns the gene SDC1 and chronic kidney disease.